Prospective, Multi-center, Non-randomized Clinical Trial of Passeo-18 Lux DCB in New and Non-stented Re-stenotic Lesions in the Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA) in a Chinese Patient Population

Trial Profile

Prospective, Multi-center, Non-randomized Clinical Trial of Passeo-18 Lux DCB in New and Non-stented Re-stenotic Lesions in the Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA) in a Chinese Patient Population

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Sep 2016

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Peripheral arterial disorders
  • Focus Adverse reactions
  • Acronyms BIOLUX-P IV CHINA
  • Sponsors BIOTRONIK
  • Most Recent Events

    • 29 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top